Analytical development is essential to ensure that mRNA and LNP products are well-characterized, safe, and consistent. Our comprehensive analytical services for mRNA support every stage of development and manufacturing, providing the rigorous data needed for global regulatory compliance and patient safety.
We utilize a diverse range of orthogonal mRNA analytical methods to assess identity, purity, integrity, and potency. This multi-faceted approach delivers reliable, reproducible results across all development and manufacturing stages.
Yes. We develop all mRNA analytical methods with scalability and robustness in mind to enable a smooth transition from the lab into cGMP manufacturing. We provide structured method transfer to Quality Control (QC) laboratories, including full qualification and validation within the cGMP environment to support long-term consistency and reliability.
Our analytical services for mRNA generate the characterization and validation data health authorities expect. Robust data packages help demonstrate product quality and consistency, support regulatory filings, and address global requirements.
